Search for: "Novozymes A/S"
Results 1 - 20
of 68
Sort by Relevance
|
Sort by Date
23 Nov 2023, 1:42 am
Ultimately, the Court has ruled that S. 3(d) does apply to biochemical substances but that the Explanation to S. 3(d) does not apply to the claimed invention and that Novozymes appeal should be allowed in part. [read post]
16 Jul 2021, 12:53 pm
Novozymes A/S v. [read post]
16 Mar 2020, 9:12 am
” Novozymes A/S v. [read post]
28 Jan 2020, 9:30 pm
EP 2771468, which named as Proprietors The Broad Institute, MIT, and Harvard College and had been opposed by Novozymes A/S, CRISPR Therapeutics GG, and several strawmen). [read post]
13 Jun 2019, 9:59 pm
Novozymes A/S, the Federal Circuit reversed a decision by the U.S. [read post]
13 Jun 2019, 9:59 pm
Novozymes A/S, the Federal Circuit reversed a decision by the U.S. [read post]
14 Feb 2019, 3:03 pm
” Novozymes A/S v. [read post]
12 Oct 2018, 6:24 am
Des Moines Register, “In Iowa, Trump Says He Kept His E15 Promises, Claims Democrats Would ‘End Ethanol’” Bloomberg, “Gene-Edited Foods Are Coming to Your Plate but Aren’t Being Regulated” inhabitat, “Nuatan Is the Bioplastic That Could Answer the Plastic Pollution Crisis” UPROXX, “This ‘Bio Plastic’ Is 100% Compostable and Poised to Change the World” BiofuelsDigest, “Novozymes’ Yeast Beast in New… [read post]
22 Jan 2018, 5:08 am
On 17 January 2018, The EPO revoked one of the Broad Institute’s patents relating to a fundamental aspect of CRISPR technology. [read post]
19 Dec 2016, 1:26 pm
Novozymes, the technology at issue relates to the production of ethyl alcohol (i.e., ethanol ) from a milled grain. [read post]
17 Dec 2016, 11:43 am
U.S. [read post]
16 Dec 2016, 8:11 am
■ Tetra Pak, “Tetra Pak Gets Closer to Fully Renewable Packaging Goal with New Aseptic Carton” ■ Danimer Scientific, “MHG Debuts New Corporate Identity” ■ Leaf Resources, “Leaf Resources And Novozymes Launch Biomass-to-Sugars Collaboration” ■ Amyris, “Amyris Partners with Queensland to Create the Leading Industrial… [read post]
13 Nov 2015, 11:40 am
Inglis, 448 F.3d 1357, 1365–66 (Fed.Cir. 2006) (finding substantial evidence supported writtendescription based on “several passages in the [patentee’s]application” and the unrebutted “testimony of [the patentee’s]expert,” which showed that skilled artisanswould understand the invention); Novozymes A/S v.DuPont Nutrition Biosciences APS, 723 F.3d 1336, 1346(Fed. [read post]
15 Dec 2014, 7:08 am
Novozymes A/S et al, 3-13-cv-00864 (WIWD December 11, 2014, Order) (Crocker, M.J.) [read post]
17 Mar 2014, 6:19 pm
Novozymes A/S, a unanimous panel of the Federal Circuit reversed a district court and held that the patent holder's conduct prior to the issuance of the patent can form a sufficient case or controversy for declaratory relief. [read post]
12 Mar 2014, 7:31 am
Novozymes’s E188P α-amylase variant claim issued as the sole claim of its ’573 patent and is the same claim that Novozymes described as interfering with the claim in Danisco’s ’240 patent. [read post]
11 Mar 2014, 7:14 pm
Novozymes A/S (Fed. [read post]
11 Mar 2014, 5:07 pm
As to the district court: The district court’s categorical distinction between pre- and post-issuance conduct is therefore irreconcilablewith the Supreme Court’s insistence on applying a flexible totality of the circumstances test, its rejection of technical bright line rules in the context of justiciability, and our own precedent. [read post]
30 Jan 2014, 7:08 am
. ** Free for in-house patent counsel, academics and R&D professionals ** Supported by AIPLA and Delaware IP Law Blog, the forum will provide you with: • a guide to improving your company’s patent application process post-AIA; • an evaluation of post-grant proceedings; • an update on litigation planning and forum shopping in Europe; and • the analysis of the recent standard essential patent (SEP) litigation between Apple and Samsung You will hear from: … [read post]
16 Oct 2013, 4:52 am
In Novozymes A/s v. [read post]
